[Treatment of glucocorticoid osteoporosis (part II)].
Nasonov
E L
EL
Department of Rheumatology, MMA of IM Sechenov.
Skripnikova
I A
IA
D045930:Anabolic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005260:Female; D017611:Fluorine Compounds / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000188:drug therapy*; D014807:Vitamin D / Q000627:therapeutic use*
D045930:Anabolic Agents; D017610:Calcium Compounds; D017611:Fluorine Compounds; D005938:Glucocorticoids; D014807:Vitamin D; D002116:Calcitonin
Lechenie gliukokortikoidnogo osteoporoza (chast' II).